President and CEO, US & Canada

President & CEO, Services

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

Market Revenues for Biological and Medical Imaging Reagents to Cross $40 Billion by 2030, Driven by Rising Diagnostic Needs and Advanced Technologies

Fierce Pharma Asia—BMS’ China asset sale; 2 biotech debuts; 2 potential deals

GE Healthcare exploring stake sale in China unit, Bloomberg News reports

Head of USCAN, Pharmacovigilance

GE HealthCare is a leading global medical technology and digital solutions innovator. The Head of Pharmacovigilance will lead and oversee all USCAN pharmacovigilance activities to ensure the safety of the company's products, involving strategic planning, implementation, and management of pharmacovigilance systems in compliance with regulatory requirements.

Director, Clinical Innovation & Research

Lead Specialist, Global Litigation & Investigations

Senior Global Leader-Ombuds and Compliance Programs

Sign up with Google

Sign in with Google